0.9 C
New York
Tuesday, December 18, 2018
- Advertisement -

Featured Authors

Editor's Pick

Indivior to launch cheaper opioid addiction drug; maintains forecast

British drugmaker Indivior Plc said on Tuesday it would launch a cheaper version of its blockbuster opioid addiction treatment drug, while maintaining its full-year profit and revenue forecast.

China first to approve AstraZeneca, FibroGen anaemia drug

China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

Financial News


Research and Dev

New Podcast

Trends in The New Value-Based Reimbursement Model